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Abstract
Background
Attention function filters and selects behaviorally relevant information. This capacity is
impaired in some psychiatric disorders and has been proposed as an endophenotype for
Attention-Deficit/Hyperactivity Disorder; however, its genetic basis remains largely
unknown. This study aimed to identify single nucleotide polymorphism (SNPs) associated
with attention function.
Materials and Methods
The discovery sample included 1655 children (7–12 years) and the replication sample
included 546 children (5–8 years). Five attention outcomes were assessed using the com-
puterized Attentional Network Test (ANT): alerting, orienting, executive attention, Hit Reac-
tion time (HRT) and the standard error of HRT (HRTSE). A Genome-wide Association
Study was conducted for each outcome. Gene set enrichment analyses were performed to
detect biological pathways associated with attention outcomes. Additional neuroimaging
analyses were conducted to test neural effects of detected SNPs of interest.
Results
Thirteen loci showed suggestive evidence of association with attention function (P<10−5) in
the discovery sample. One of them, the rs4321351 located in the PID1 gene, was nominally
PLOS ONE | DOI:10.1371/journal.pone.0163048 September 22, 2016 1 / 18
a11111
OPENACCESS
Citation: Alemany S, Vilor-Tejedor N, Bustamante
M, Pujol J, Macià D, Martı´nez-Vilavella G, et al.
(2016) A Genome-Wide Association Study of
Attention Function in a Population-Based Sample
of Children. PLoS ONE 11(9): e0163048.
doi:10.1371/journal.pone.0163048
Editor: Yong-Gang Yao, Kunming Institute of
Zoology, Chinese Academy of Sciences, CHINA
Received: June 17, 2016
Accepted: September 1, 2016
Published: September 22, 2016
Copyright:© 2016 Alemany et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: In order to protect
participant’s privacy, data at individual level cannot
be made publicly available. Full summary statistics
can be found in the paper and supporting
information. For further details, authors can be
contacted at http://www.isglobal.org/ca/.
Funding: The research leading to these results has
received funding from the European Research
Council under the ERC Grant Agreement number
268479 – the BREATHE project. The INMA project
was funded by grants from Instituto de Salud
Carlos III (Red INMA G03/176 and CB06/02/0041).
significant in the replication sample although it did not survive multiple testing correction.
Neuroimaging analysis revealed a significant association between this SNP and brain
structure and function involving the frontal-basal ganglia circuits. The mTOR signaling and
Alzheimer disease-amyloid secretase pathways were significantly enriched for alerting, ori-
enting and HRT respectively (FDR<5%).
Conclusion
These results suggest for the first time the involvement of the PID1 gene, mTOR signaling
and Alzheimer disease-amyloid secretase pathways, in attention function during childhood.
These genes and pathways have been proposed to play a role in neuronal plasticity, mem-
ory and neurodegenerative disease.
Introduction
Attention is a cognitive function essential in daily life. Every day, our perceptual systems are
exposed to a massive internal and external sensory input for which the relevant behavioural
information is selected and prioritized [1, 2]. Attention function allows the selection and prior-
itization of stimuli by activating different neural systems that interact with each other in a com-
plex manner. It has been proposed that three functionally and anatomically different networks
are involved in this process: alerting, orienting and executive attention [3]. According to Posner
and Rothbart (2009), ‘alerting is defined as achieving and maintaining a state of high sensitivity
to incoming stimuli; orienting is the selection of information from sensory input; and executive
attention involves mechanisms for monitoring and resolving conflict among thoughts, feelings,
and responses’ [3].
From a developmental perspective, attention constitutes a precursor of other higher-level
cognitive abilities such as learning and memory [4]. Therefore, attention function plays a key
role in cognitive development. From a clinical perspective, attention function is impaired in
neuropsychiatric disorders such as Attention-Deficit/Hyperactivity Disorder (ADHD) and
schizophrenia [5–9], thus, research in attention may have etiological implications for these dis-
orders. These facts highlight the relevance of investigating the sources of variation of attention
function.
Although experienceswith the caregivers, education and other exposures account for indi-
vidual variation in cognitive functions, the development of attention is partly specifiedby
genes [3]. Genetic effects on attention function variation have been found early in life [10]. The
catechol-O-methyltransferase gene (COMT) and the dopamine D4 receptor gene (DRD4) are
among the candidate genes for attention function development [1, 10, 11]. However, these
studies found modest associations and they failed to identify consistent and replicable results.
A twin study including only 26 pairs estimated the heritability of the abovementioned attention
networks ranging from 0% for orienting to 72% for executive attention [12]. Other studies
report low to moderate (28–38%) and high (79%) heritability estimates for attention function
[13, 14]. Therefore, although we can expect genetic influences on attention function develop-
ment, there is still scarce knowledge about the genetic basis of attention in general population.
Furthermore, to our knowledge, there are no previous genome-wide association studies
(GWAS) on attention function during childhood.
GWAS on Attention Function during Childhood
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The main goal of the present study was to identify common genetic variants associated with
attention at a genome-wide level. The steps followed include: i) identification of single nucleo-
tide polymorphisms (SNPs) associated with attention, ii) replication of significant findings in
an independent sample, iii) search for relevant biological pathways accumulating associated
genetic variants using gene set enrichment analyses (GSEA) and iv) examination of potential
association between relevant identified SNPs and variations in brain structure and function
using neuroimaging tools.
Materials and Methods
Discovery sample
The discovery sample was obtained from the BRain dEvelopment and Air polluTion ultrafine
particles in scHool childrEn (BREATHE) project aimed to analyze the association between air
pollution and cognitive development of scholars [15]. From the total of 2897 children partici-
pating in this project, genotypic and neurocognitive data was available for 1655 individuals. All
parents and legal guardians signed the informed consent approved by the Clinical Research
Ethical Committee (No. 2010/41221/I) of the Institut Hospital del Mar d’Investigacions Mèdi-
ques–Parc de Salut Mar, Barcelona, Spain.
Replication sample
The replication sample included 546 children from the INfancia y Medio Ambiente (INMA)
multicenter birth cohort project recruited in the cities of Sabadell and Valencia (Spain)
(INMA-SabVal) [16]. All parents and legal guardians signed the informed consent approved
by the Clinical Research Ethical Committee of the Institut Hospital del Mar d’Investigacions
Mèdiques–Parc de Salut Mar, Barcelona and institutional ethics committees in each region.
Measures
Attention functionwas assessed using the computerized Attentional Network Test [ANT; [17]]
which assesses three attentional networks: alerting, orienting and executive attention. The com-
puterized version of this test has been validated with brain imaging [17] and in the general pop-
ulation [18]. As part of the BREATHE project, a follow-up with four repeated measurements of
the attention functionwere conducted in a period of a year. The outcomes analyzed herein cor-
respond to the first administration of the test. Five attention outcomes were analyzed in the
current study: alerting, orienting, executive attention, hit-reaction time (HRT) and the stan-
dard error of the HRT (HRTSE). Reaction time (RT) measures (i.e. time between the introduc-
tion of a stimulus and the reaction on the subject to that stimulus) were used to calculate
alerting (RT for no cue minus RT for double cue trials), orienting (RT for central cue minus
RT for spatial cue trials) and executive function (RT for incongruentminus RT for congruent
trials) scores. HRT (Median RT for correct responses) and HRTSE (Standard error or RT for
correct responses) were also analyzed as measures of variability. All the outcomes analyzed
were continuous variables. Higher scores indicate worse performance. Children with>30%
errors were excluded from the analysis. Further details can be found elsewhere [18].
Study Design, Genotyping and quality control
To identify novel loci associated with attention outcomes, we conducted a GWAS with follow-
up of associations at suggestive evidence (P<10−5) in the replication sample.
In the discovery sample, DNA samples from 2492 children were obtained from saliva col-
lected in Oragene DNA OG-500kit (DNA Genotek) following instructions of the manufacturer
GWAS on Attention Function during Childhood
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with minor modifications.DNA samples were quantified using Quant-iT™ PicoGreen1
dsDNA Assay Kit (Life Technologies). A final subset of 1778 children was selected for genome-
wide genotyping after applying a filtering criteria (low quality DNA, no neuropsychological
data, non Caucasian descent origin and not born in Spain, parents born in Europe, and adopted
children). Genome-wide genotyping for the discovery sample was performed using the
HumanCore BeadChipWG-330-1101 (Illumina) at the Spanish National Genotyping Centre
(CEGEN) coordinated by the Spanish National Cancer Research Centre CNIO). Genotype call-
ing was done using the GeneTrain2.0 algorithm (with a default threshold of 0.15) based on
HapMap clusters implemented in the GenomeStudio software. Twenty CEUHapMap dupli-
cates and twenty BREATHE duplicates were included in the study and gave consistent results.
PLINK was used for the genotyping quality of the sample and SNPs [19]. Quality control
procedures were samples with a minimum of 97% call rate (N = 3 exclusions) and a maximum
of 4 SD heterozigosity were included (N = 5 exclusions). Further checking was conducted for
gender discordance excluding mismatch information (N = 18 exclusions, representing 1% of
the sample), sample relatedness excluding proportions of identity by-state above 0.185 (N = 80
exclusions: 1 twin, 32 siblings, 39 cousins, 8 incongruent sibling's couples) and population
stratification. Five subjects were excluded due to mental disabilities. In total we excluded 111
subjects (6.26%) leaving 1667 individuals from who 1655 have data available for the attention
outcomes considered in the present study.
Genetic variants were filtered by Hardy-Weinberg equilibrium (P<10−6), allele frequency
(excluding minor allele frequency (MAF<1%) and SNP call rate with a minimum of 95%. In
total, 58827 genetic variants (19.68%) were excluded. The final discovery genetic data set
included 240103 SNPs.
The replication cohort was genotyped using the HumanOmni1-Quad v1.0 Beadchip (Illu-
mina) at the CEGEN. Quality control procedures for the replication sample were also per-
formed in PLINK. Samples with a minimum of 98% call rate and a maximum of 3 SD
heterozigosity were included. Furthermore, gender discordance, sample relatedness (excluding
proportions of identity by-state above 0.185) and population stratification were checked.
Genetic variants were filtered using the same criteria as in the discovery sample. The final repli-
cation sample included 546 subjects.
Statistical Analysis
We used a two-sample t-test to check for differences in ANT outcomes and age, and a Pear-
son’s χ2 test to check for sex differences. Genome-wide association analyses were conducted
using linear regression models in SNPtest [20]. Separate models were tested for each ANT out-
come as dependent variables and genetic markers as predictors. Additive genetic models were
assumed to assess the association of each SNP with each ANT outcome, adjusting for age, sex
and school.
Quantile-quantile (Q-Q) and Manhattan plots were computed using the qqman package of
R. Genome-wide significancewas set at P<5x10-8, and suggestive evidence of association was
set at P<10−5. These thresholds have been recommended by a simulation study taking into
account linkage disequilibrium (LD) between SNPs [21]. SNPs showing an association with
attention outcomes (at GWAS or suggestive significance)were taken forward for replication in
the INMA-SabVal sample. In the replication sample, multiple linear regressions in SNPtest
adjusting by age, sex and cohort were conducted. In order to be replicated, SNPs must be nomi-
nally significant (P<0.05) after multiple testing correction (FDR<0.05).
To further analyze the association signal, regions which include SNPs of potential interest
for cognitionwere imputed using IMPUTE2 v2 [20] taking the 1000 Genomes project phase I
GWAS on Attention Function during Childhood
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integrated variant set (http:/www.1000genomes.org/) as a reference haplotype panel. Regional
association plots were computed with LocusZoom[22].
In addition, potentially relevant SNPs detectedwere analyzed for associations with gene
expression using the Brain expression quantitative trait loci (eQTL) Almanac (http://www.
braineac.org/) [23]. BRAINEAC is a publicly accessible database which contains gene expres-
sion data (generated eQTL) analyzed in ten brain regions from postmortem human brains.
Gene set enrichment analyses (GSEA) were conducted using Meta-Analysis Gene-set
Enrichment of variaNT Associations (MAGENTA) software (19) for each attention outcome.
Data sources included Reactome, Panther, KEGG and Ingenuity. As described in detail previ-
ously [24], MAGENTA individuallymapped genes in the genome to the lowest P-value single
SNP within a 110kb upstream and 40kb downstream window. These P-values were adjusted
for confounding factors (e.g. physical gene size, number of SNPs per kilobase for each gene and
other genetic properties). Genes are then ranked according to these adjusted P-values, and the
gene-set enrichment P-value for each biological pathway was calculated for a given significance
threshold (95th percentile). To test whether genes were enriched in a pathway more than would
be expected by chance, this value was compared with that generated with randomly permuted
pathways of identical size. Individual pathways that reached FDR<0.05 were deemed signifi-
cant and results for the 95th percentile cut-off analysis were reported.
Neuroimaging analyses
To further understand the role of SNPs of potential interest for cognition, its effects on brain
structure and functionwere examined in a subsample of 185 children drawn from the
BREATHE project who underwent neuroimaging studies with genetic and cognitive data avail-
able. More details in [25]. The imaging approach included whole-brainmapping of cortical
thickness using high resolution 3D anatomic MRI, fractional anisotropy (FA) from diffusion
tensor imaging (DTI) and resting-state functional connectivity in selected relevant large-scale
networks [26–28]. Further details can be found in S1 Text.
MRI acquisition was performed using a 1.5 Tesla Signa Excite system (General Electric,Mil-
waukee, WI, USA) equipped with an eight-channel phased-array head coil and single-shot
echo planar imaging (EPI) software was used (further details can be found in S1 Text.
Imaging data were analyzed using Statistical Parametric Mapping (SPM8) (http://www.fil.
ion.ucl.ac.uk/spm,Wellcome Department of CognitiveNeurology, London, UK, 2008). Indi-
vidual anatomical (cortical thickness), DTI and functional connectivitymaps were included in
second-level (group) analyses to map voxel-wise the correlation across-subjects between indi-
vidual brain measurements and the SNP of interest. Results were considered significant with
clusters of 1.032 ml (e.g., 129 voxels with a resolution of 2x2x2 mm) at a height threshold of
p<0.005, which satisfied the family-wise error (FWE) rate correction of PFWE<0.05 according
to recent Monte Carlo simulations [29]. Maps in figures are displayed at t>2.3.
Results
Descriptive results
Table 1 shows age, sex ratio and scores for the five attention outcomes of the discovery
(BREATHE) and replication sample (INMA-SabVal). Within BREATHE sample, girls showed
a better performance in executive attention [t(1493) = 4.21; P<0.001], but a worse performance
in HRT [t(1493) = -8.39; P<0.001] and HRTSE [t(1493) = -5.63; P<0.001], compared to boys.
Similar findings were observedwithin INMA-SabVal sample, in regard to sex differences for
HRT [t(544) = 6.1; P<0.001] and HRTSE [t(544) = 4.6; P<0.001].
GWAS on Attention Function during Childhood
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Genome-wide association study: Discovery sample
Q-Q plots of the observedversus expected P-values and Manhattan plots showing the distribu-
tion of negative log-transformed P-values for every attention outcome are provided in Figs 1
and 2a. The Q-Q plots showed no departure from the expected P-values distribution. Genomic
control inflation factor (λ) is included in each Q-Q plot.
No SNPs were genome-wide significant (P<10−8). Nevertheless, 13 loci showed suggestive
evidence of association with attention outcomes (Table 2).
The SNP with the strongest association was the rs4775379 SNP (β = 35.9, P = 6.98 x 10−7)
associated with HRT (Table 2). The nearest gene to this intergenic SNP located on chromo-
some 15 is the sulfide quinone reductase-like (SQRDL) gene. The secondmost significant SNP
was the rs10911457, associated with orienting (β = 13.1, P = 10.0 x 10−7), located on chromo-
some 1 in the Ral guanine nucleotide dissociation stimulator-like 1 (RGL1) (Table 2).
Top five most significant SNPs associated with each attention outcome can be found in S1
Table. Full summary statistics for all SNPs tested in each attention outcome can be found in
S1–S5 Files.
Genome-wide association study: Replication sample
The rs4321351 was nominally significant in the replication sample, although neither this SNP
nor the others showing suggestive evidence of association with the attention outcomes
remained significant after multiple testing correction (FDR<0.05).
The nominally significant SNP associated with HRT in the discovery sample (β = -29.0,
P = 3.35 x 10−6) showed same direction of additive effect in INMA-SabVal sample (β = -27.7,
P = 0.025) (Table 3). HRT scores decreased as a function of the G allele copies of the rs4321351.
This SNP is located in an intronic region of the phosphotyrosine interaction domain containing
1 (PID1) gene. Regional association analysis within 1Mb of this loci (chr2:230129493) identified
a linkage disequilibrium (LD) block of 18 SNPs (r2> 0.8) yielding strong evidences of multiple
association signals for HRT (Fig 2).
The eQTL analysis for rs4321351 indicated that PID1 and DNER genes were among the top
ten most affected genes by this SNP. Moreover, exon-specific probesets in PID1 (ID: 2602738)
and DNER (ID: 2602778) genes were expressed in putamen (p = 0.004 and p = 0.009, respec-
tively) according to BRAINEAC database (S2 Table).
Gene set enrichment analysis results
Among the total of 195 functional pathways nominally associated with the attention outcomes
(P<0.05), three remained significant after correcting for multiple testing (FDR<5%) (Table 4).
The strongest enrichment was found for the alerting attention outcome involving the
Table 1. Descriptive data for the variables of the study for the discovery (Breathe) and replication (INMA-SabVal) samples. Percentage is indicated
for categorical variables. Mean, SD and maximum and minim are indicated for continuous variables.
Breathe (n = 1655) INMA-SabVal (n = 546) Comparison
Sex, females (%) 789 (47.7%) 266 (48.7%) Chi(1) = 0.3415; P = .599
Age 9.2 (.87) (7.5/11.6) 7.12 (0.48) (5.36/8.55) t(1738) = 71.62; P < .001
Alerting 48.3 (76.1) (-337.5/424) 54.37 (92.9) (-450/448) t(826) = -1.35; P = .175
Orienting 36.8 (74.3) (-297/403) 33.31 (92.86) (-407.5/329) t(813) = 0.78; P = .432
Executive Attention 62.2 (58.0) (-182/557) 79.95 (84.63) (-185.5/646.5) t(740) = -4.52; P < .001
HRT 803.9 (160.4) (438/1501) 941.11 (186.84) (594.5/1724.5) t(855) = -15.23; P < .001
HRTSE 266.3 (87.2) (76.5/528.5) 317.12 (78) (97.25/507.99) t(1074) = -12.63; P < .001
doi:10.1371/journal.pone.0163048.t001
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Fig 1. Quantile-quantile (Q-Q) plots (left side) and Manhattan plots (right side) of genome-wide
association analyses for (a) alerting, (b) orienting, (c) executive attention, and (d) HRTSE attention
outcomes in the discovery sample. Genomic inflation factor (λ) is included in each Q-Q plot. The blue line
in the Manhattan plots indicates the suggestive level of statistical significance (P<10−5).
doi:10.1371/journal.pone.0163048.g001
GWAS on Attention Function during Childhood
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Fig 2. a) Quantile-quantile and Manhattan plot of genome-wide association results for HRT. The blue line indicates the suggestive
level of statistical significance (p<10−5). b) Diagram of the chromosome 2. The red line indicates the position of the rs4321351
(230,129,493 bp). c) Regional association plot of rs4321351 located in PID1 gene. The linkage disequilibrium (LD; r2) between the
SNP in focus and its SNPs genotyped or imputed within 1Mb is showed in red (high LD) to blue (low LD). The recombination rate is
plotted in blue according to HapMap (CEU).
doi:10.1371/journal.pone.0163048.g002
GWAS on Attention Function during Childhood
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Alzheimer disease-amyloid secretase pathway (P = 9.40x10-5; FDR = 0.014) followed by the sex
determination pathway associated with orienting (P = 6.00x10-4; FDR = 0.007). Also, a signifi-
cant association was found for the mammalian target of rapamycin (mTOR) signalling path-
way (P = 4.00x10-4; FDR = 0.043) for the HRT attention outcome.
Table 2. SNPs associated with attention function outcomes at P<10−5 (ordered by significance).
Attention outcome SNP CHR position Allelea MAF N β SE P-value Gene Nearest gene
Alerting rs10015679 4 40644376 T/C 0.319 1491 -13.80 3.00 4.10 x 10−6 Intergenic RBM47
rs13048083 21 28286853 T/C 0.247 1491 -14.48 3.23 7.33 x 10−6 Intergenic ADAMTS5
Orienting rs10911457 1 183843104 T/C 0.461 1492 13.14 2.69 9.99 x 10−7 RGL1 -
rs12579294 12 3289945 T/C 0.222 1492 -14.84 3.23 4.46 x 10−6 TSPAN9 -
rs4629469 4 36419047 G/A 0.357 1490 12.76 2.82 5.95 x 10−6 Intergenic DTHD1
Executive Attention rs2207190 1 171415856 G/A 0.405 1493 -9.84 2.16 5.12 x 10−6 Intergenic PRRC2C
rs2320783 8 25009089 G/A 0.134 1493 -14.27 3.17 6.82 x 10−6 Intergenic DOCK5
HRT rs4775379 15 46682794 T/C 0.216 1484 35.87 7.23 6.98 x 10−7 Intergenic SQRDL
rs951738 13 45479633 G/A 0.234 1442 32.85 6.99 2.60 x 10−6 Intergenic NUFIP1
rs757594 17 12000632 G/A 0.233 1493 33.09 7.11 3.25 x 10−6 MAP2K4 -
rs4321351 2 230129493 G/A 0.318 1493 -28.99 6.24 3.35 x 10−6 PID1 -
rs6593376 10 44469148 T/C 0.215 1493 32.31 7.08 5.02 x 10−6 Intergenic LINC00841
HRTSE rs1560054 5 111519018 T/C 0.282 1493 -16.95 3.59 2.29 x 10−6 EPB41L4A -
SNP, single nucleotide polymorphism; CHR, chromosome; MAF, minor allele frequency; β, regression coefficient; SE, standard error.
a Effect allele/Other allele
RBM47, RNA binding motif protein 47; ADAMTS5, ADAM metallopeptidase with thrombospondin type 1 motif, 5; RGL1, Ral guanine nucleotide dissociation
stimulator-like 1; TSPAN9, tetraspanin 9; DTHD1, death domain containing 1; PRRC2C, proline-rich coiled-coil 2C; DOCK5, dedicator of cytokinesis 5;
SQRDL; sulfide quinone reductase-like; NUFIP1, nuclear fragile X mental retardation protein interacting protein 1; MAP2K4, dual specificity mitogen-
activated protein kinase kinase 4; PID1, phosphotyrosine interaction domain containing 1; LINC00841, long intergenic non-protein coding RNA 841;
EPB41L4A, erythrocyte membrane protein band 4.1 like 4.
doi:10.1371/journal.pone.0163048.t002
Table 3. SNPs replicated in INMA-SabVal sample.
Attention outcome SNP CHR position Allelea MAF N β SE P-value FDR
Alerting rs10015679 4 40644376 T/C 0.324 545 2.95 6.08 0.628 0.891
rs13048083 21 28286853 T/C 0.247 545 6.60 6.45 0.307 0.891
Orienting rs10911457 1 183843104 C/T 0.454 546 5.10 5.65 0.367 0.891
rs12579294 12 3289945 T/C 0.221 546 -10.09 6.98 0.148 0.858
rs4629469 4 36419047 G/A 0.376 546 3.69 5.71 0.517 0.891
Executive Attention rs2207190 1 171415856 G/A 0.430 545 -0.33 5.15 0.949 0.949
rs2320783 8 25009089 G/A 0.146 545 -3.15 7.21 0.662 0.891
HRT rs4775379 15 46682794 T/C 0.253 546 -4.46 12.74 0.726 0.891
rs951738 13 45479633 A/G 0.241 546 5.65 12.69 0.656 0.891
rs757594 17 12000632 A/G 0.254 546 -1.92 12.93 0.882 0.949
rs4321351 2 230129493 G/A 0.321 546 -27.74 12.32 0.025 0.325
rs6593376 10 44469148 T/C 0.228 546 -17.25 13.40 0.198 0.858
HRTSE rs1560054 5 111519018 C/T 0.287 546 1.59 5.08 0.754 0.891
SNP, single nucleotide polymorphism; CHR, chromosome; MAF, minor allele frequency; β, regression coefficient; SE, standard error.
a Effect allele/Other allele
doi:10.1371/journal.pone.0163048.t003
GWAS on Attention Function during Childhood
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Top five most significant pathways associated with each attention function outcome can be
found in S3 Table.
Neuroimaging results
Although none of the SNPs were replicated, we further explored the nominally significant
SNP.
Significant associations were detected between the rs4321351 in PID1 gene and changes in
both fractional anisotropy (FA) in DTI and functional connectivity. Specifically, carriers of the
G allele of the rs4321351 presented lower FA values in the basal ganglia compared with homo-
zygotes for the A allele (S4 Table and Fig 3a). Interestingly, lower FA in nearby white matter
was associated with lower HRT (Fig 3a). Also, lower HRT was associated with thinner cortical
thickness in the adjacent anterior cingulate cortex in the left hemisphere (Fig 3b). Functional
results were also consistent with an effect of the SNP in frontal-basal ganglia circuits. In the
medial frontal seedmap, functional connectivity between the frontal medial cortex (selected
seed region) and the prefrontal cortex bilaterally increased as a function of the G copies of the
rs4321351 (S4 Table and Fig 3c). Increased functional connectivity in this map was associated
with lower HRT involving both prefrontal cortex and anterior cingulate cortex (S4 Table and
Fig 3c). Finally, in the frontal operculum seedmap, carriers of the G allele presented higher
functional connectivity between the frontal operculum and the basal ganglia at the putamen
bilaterally (S1 Fig).
It is relevant to mention that the association between increased connectivity and lower HRT
as a function of the G allele copies of the rs4321351, concerns almost selectively to the frontal-
basal ganglia system; as posterior brain areas (i. e., parietal cortex), show the opposite associa-
tion pattern (S4 Table).
Discussion
To our knowledge, this is the first GWAS on attention function assessed in children from the
general population. No genome-wide significant results were detected but 13 loci were identi-
fied in the suggestive range of association (P<10−5) in the discovery sample. One of them, the
rs4321351 located in the PID1 gene, was nominally significant in the replication sample
although it did not survivemultiple testing correction. This signal was further explored due to
its potential relationship with the findings at the pathway level involving Alzheimer disease
(AD).
The PID1 gene increases proliferation of preadipocytes without affecting adipocytic differ-
entiation [30]. Studies examining PID1 has beenmostly in the context of obesity and insulin
resistance [30–33]. Overexpression of PID1 in human myoblasts results in reduced insulin sig-
naling [31] which has been pointed out as a neuroprotective agent acting mainly against apo-
ptosis, beta amyloid toxicity, oxidative stress, and ischemia [34]. Indeed, insulin signaling has
Table 4. Gene set enrichment analysis (GSEA). Pathways significantly associated with attention outcomes after applying multiple testing correction.
Nominal 95th Percentile
Outcome Data Base Gene Set Size (n˚ of genes) Expected Observed P-value FDR
Alerting PB Sex determination 9 0 4 6.00 x 10−4 0.007
Orienting RE mTOR signalling 27 1 7 4.00 x 10−4 0.043
HRT PA Alzheimer disease-amyloid secretase pathway 23 1 7 9.40 x 10−5 0.014
RE, Reactome; PA, Panther; PB, Panther-Biological process
doi:10.1371/journal.pone.0163048.t004
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been found to be impaired in brains of patients with AD [35]; and type 2 diabetes, character-
ized by insulin resistance or lack of insulin, has been proposed as a risk factor for AD [36, 37].
Furthermore, PID1 expression has been found to be significantly decreased in brains of patients
with AD compared with controls [38]. These evidences suggest the involvement of PID1 gene
Fig 3. Diffusion tensor imaging results showed significantly lower fractional anisotropy (FA) in the region of the basal ganglia as a function of
the G allele copies of the rs4321351 (a, left image). Lower HRT scores correlated with lower FA in this region bilaterally (a, right image) and with thinner
anterior cingulate cortex (b) (cortical area of 1.2 cm2 centered at MNI, x = -6 y = 2 z = 32, Pcorrected <0.05). Functional connectivity results from the medial
frontal seed map (c) showing prefrontal regions with significantly higher functional connectivity as a function of the G allele copies of the rs4321351. Lower
HRT scores correlated with higher functional connectivity also in the prefrontal cortex, and in the anterior cingulate cortex. T denotes statistics t value.–log10
p denotes log of the probability p value. The right side corresponds to the right hemisphere in coronal and axial images.
doi:10.1371/journal.pone.0163048.g003
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in neuronal processes and neurodegenerative disease. Our findings add to these evidences
relating this gene with attention function during childhood.
Although the rs4321351 SNP was located within the PID1 gene, fine-mapping results
showed that the LD region was close to the Delta and Notch-like epidermal growth factor-
related receptor (DNER) gene. Thus, we cannot discard that this SNP may be responsible for
regulation of theDNER gene rather than PID1 gene. DNER is a neuron-specificNotch ligand
required for cerebellar development [39–41]. Also, theDNER gene functions as an activator of
the NOTCH1 pathway which has also been related to AD and postnatal myelination and adult
plasticity [42, 43]. Furthermore, copy number variations in DNER have been associated with
autism spectrumdisorders [44].
Additional neuroimaging analyses revealed significant associations between the genetic var-
iant rs4321351 located at PID1 gene and both brain structure and functionwith the most con-
sistent findings involving the frontal-basal ganglia circuits. This is in accordance with models
of attention consistently suggesting the interaction of cortical structures such as frontal cortex
with subcortical structures such as basal ganglia to form a complex functional system impli-
cated in sustained attention processes [45, 46]. Relevantly, individual measurement of structure
and function in frontal-basal ganglia circuits showed, in turn, significant correlations with
HRT where G allele carriers presented higher connectivity between these regions. The direction
of the imaging results was in agreement with GWAS findings indicating that HRT scores
decreased as a function of the G allele copies of the rs4321351. Furthermore, analyses based in
BRAINEAC database showed that rs4321351 may act as eQTL in putamen, one of the struc-
tures comprising basal ganglia. Thus, the imaging and eQTL results reinforce the possibility
that this SNP may play a role in neuronal structure and functioning related to HRT.
At the pathway level, three biological pathways were significantly associated with different
attention outcomes. The sex determination pathway refers to any process that establishes and
transmits the specification of sexual status of an individual organism. To our knowledge, nei-
ther the current findings nor previous research provide clear clues to link this pathway with
alerting.Of note, no sex differences were detected in alerting scores. Thus, the possible role of
this pathway in attention development requires replication. In contrast, the other two pathways
identified, the mTOR singalling pathways and the Alzheimer disease-amyloid secretase path-
way involve processes of interest for cognition which, again involve AD.
The mTOR is a ubiquitously expressed protein kinase that functions as a regulator of several
cellular processes including metabolism, growth, proliferation and survival [47]. There is evi-
dence supporting the role of mTOR signaling in synaptic plasticity and memory [48] and it has
been suggested that dysregulation of mTOR signalingmight be associated with neurodevelop-
mental, neurodegenerative and neuropsychiatric disorders [49–51]. Biological plausability for
these evidences regards the modulating function of mTOR in autophagy since this signaling
pathway receives inputs regarding the energetic state of the cell in order to trigger or stop the
synthesis of proteins. Also, kinasemTOR is a downstream target of two other pathways, the
phosphatidylinositol 3 kinase (PI3K) and kinase AKT (AKT) pathway, which together would
downregulate autophagy while fostering cell growth, differentiation and survival. Therefore,
activation of the PI3K/AKT/mTOR pathway would promote survival, neuronal protection,
and inhibition of autophagy by mTOR activation. [50]. Interestingly, autophagy, which is par-
tially modulated by mTOR as abovementioned, plays a critical role in multiple pathological
lesions of AD, such as the formation of amyloid plaques [52] which is related to the second
enriched pathway associated with attention function in our study. The AD amyloid secretase
pathway refers to the role of the amyloid precursor protein (APP) in the formation of amyloid
plaques in AD. However, APP is not only linked to this pathologic process, it has been sug-
gested that APP is also involved in neurite outgrowth and synaptogenesis, neuronal protein
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trafficking along the axon, transmembrane signal transduction, cell adhesion, and calcium
metabolism [53].
Other relevant findings include the nearest gene to the top hit SNP (rs4321351 associated
with HRT at p = 6.98 x 10−7) the sulfide quinone reductase-like (SQRDL) gene, the rs10911457
(associated with orienting at p = 9.99 x 10−7) located in the Ral guanine nucleotide dissociation
stimulator-like 1 (RGL1) gene, and the proline-rich coiled-coil 2C (PRRC2C) gene (nearest
gene of the rs2207190 associated with executive attention at p = 5.12x10-6). The SQRDL is a
protein-coding gene which product may function in mitochondria to catalyze the conversion
of sulfide to persulfides, thereby decreasing toxic concencrations of sulfide. This gene has been
related to ethylmalonic encephalopathy disease [54] and there is evidence indicating that
SQRDL is expressed in neurons, oligodendrocytes, and endothelial cells [55]. The RGL1 gene is
involved in Ras and Ral GTPase signaling pathways as a downstream effector protein. Interest-
ingly, it has been suggested that the functions of the Ras and Ral signaling pathways also extend
into neuronal differentiation and outgrowth [56]. Furthermore, the RGL1 gene has been associ-
ated with conduct problems in a GWAS of children with ADHD [57]. Of note, the SNP associ-
ated with conduct problems in the study of Anney and collaborators [57] (rs10797919) is in
linkage disequilibrium (LD) (r2 = 0.60; D’ = 0.94) with the SNP within the RGL1 gene associ-
ated with orienting in the current study (rs10911457). It might be plausible that the RGL1 gene
and its product may play a role in attention. Interestingly, the PRRC2C gene associated has
been associated with cognitive decline in AD [58].
Of note, besides the eQTL results regarding rs4321351, the possible functionality of the
genetic variants discussed above is currently unknown. To our knowledge, none of the loci
were in linkage disequilibriumwith any potential functional coding SNP.
It is worth mentioning that most of the relevant findings discussed above involved the HRT
and HRTSE attention outcomes. Reaction Time (RT) variability is one of the most replicated
deficits in ADHD [59] and previous research highlights RT as a promising cognitive target for
molecular genetics investigation [60].
The current results should be interpreted considering its limitations and strengths. First, the
main limitation of the study is the modest sample size which may increase type II error. Sec-
ond, we examinedmultiple phenotypes under a massive univariate approach which may inflate
type 1 error. Thus, further research and replication in larger samples are needed. That said, the
strengths of the study include several aspects to overcome these limitations including, i) the use
of quantitative traits and application of gene set enrichment analyses which helps increasing
the power of the study, ii) the inclusion of a replication sample of a similar age and assessed
with the same instrument, and iii) additional neuroimaging analyses using different techniques
to get insight into the possible neural effects of the genetic variant replicated. Thus, while type
II error may only be solved by increasing sample size, several genetic loci showed suggestive
evidence for association with the attention outcomes analyzed. Although none of the loci was
further replicated when adjusting by multiple testing, one SNP was nominally associated with
the same outcome in an independent sample. Furthermore, this locus showed significant asso-
ciations with different neuroimaging techniques assessing brain structure and function con-
verging in frontal-basal ganglia connections, previously associated with attention and reaction
time, as abovementioned. At pathway level, several interesting biological pathways were associ-
ated with the attention outcomes assessed underscoring proteins of interest for cognition such
as mTOR and APP. Also, we used a computerized test to assess attention, the ANT, which pro-
vides homogeneous and reliable measures of attention function [17]. For these reasons, while
we cannot discard that other potential genetic variants of interest would be detected in larger
samples, we believe that it is unlikely that our results may be false positives since the loci,
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pathways and neuroimaging results obtained are likely to be biologicallymeaningful for atten-
tion function research.
To conclude, the current study has identified a new promising locus (rs4321351) which may
be involved in attention function during childhood and is associated with brain structural and
functional changes. Furthermore, to our knowledge, this is the first study suggesting that the
PID1 and theDNER genes, the mTOR and the amyloid precursor pathways, proposed to be
involved in the pathogenesis of AD, may play a role in the development of attention function
during childhood. Evidences from previous studies also suggest that cognitive functions
assessed in nondemented populations may share common genetic factors with neurodegenera-
tive disorders such as AD. AD related pathways were associated with attention outcomes in
adults affected by ADHD [24]. A marginal joint effect of established AD genes was found on
memory in a population-based sample of nondemented middle-aged and elderly subjects [61].
Remarkably, a recent GWAS of cognitive functions and educational attainment in UK Biobank
identified genomic regions previously associated with neurodegenerative disorders and AD
[62]. Thus, further research is needed to elucidate whether AD and attention function develop-
ment may share common genetic and biological pathways that can be detected early in life
through GWAS methodologies.
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